These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 15653109)

  • 21. The Pilot Randomized Study of Nesiritide Versus Dobutamine in Heart Failure (PRESERVD-HF).
    Gheorghiade M; Gattis Stough W; Adams KF; Jaffe AS; Hasselblad V; O'Connor CM
    Am J Cardiol; 2005 Sep; 96(6A):18G-25G. PubMed ID: 16181819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Brain natriuretic Peptide. Diagnostic and prognostic value in chronic heart failure].
    Krüger S; Hoffmann R; Graf J; Janssens U; Hanrath P
    Med Klin (Munich); 2003 Oct; 98(10):562-7. PubMed ID: 14586510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study.
    McCullough PA; Duc P; Omland T; McCord J; Nowak RM; Hollander JE; Herrmann HC; Steg PG; Westheim A; Knudsen CW; Storrow AB; Abraham WT; Lamba S; Wu AH; Perez A; Clopton P; Krishnaswamy P; Kazanegra R; Maisel AS;
    Am J Kidney Dis; 2003 Mar; 41(3):571-9. PubMed ID: 12612980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Brain natriuretic peptide and QRS duration as a predictor for cardiac events in patients with heart failure].
    Taniguchi T; Kawasaki T; Miyai N; Kamitani T; Kawasaki S; Sugihara H
    J Cardiol; 2006 Jun; 47(6):277-83. PubMed ID: 16800370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroendocrine testing in community patients with heart disease: plasma N-terminal proatrial natriuretic peptide predicts morbidity and mortality stronger than catecholamines and heart rate variability.
    Nielsen OW; Rasmussen V; Christensen NJ; Hansen JF
    Scand J Clin Lab Invest; 2004; 64(7):619-28. PubMed ID: 15513318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of exercise on natriuretic peptides in plasma and urine in chronic heart failure.
    Bentzen H; Pedersen RS; Nyvad O; Pedersen EB
    Int J Cardiol; 2004 Feb; 93(2-3):121-30. PubMed ID: 14975537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure.
    de Groote P; Dagorn J; Soudan B; Lamblin N; McFadden E; Bauters C
    J Am Coll Cardiol; 2004 May; 43(9):1584-9. PubMed ID: 15120815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure.
    Kinugawa T; Kato M; Ogino K; Osaki S; Igawa O; Hisatome I; Shigemasa C
    J Card Fail; 2003 Aug; 9(4):318-24. PubMed ID: 13680553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure.
    Horwich TB; Patel J; MacLellan WR; Fonarow GC
    Circulation; 2003 Aug; 108(7):833-8. PubMed ID: 12912820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure, renal failure and cancer?
    Vesely DL
    Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):169-76. PubMed ID: 16487258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlations between cardiac troponin I, cardiac troponin T, and creatine phosphokinase MB elevation following successful percutaneous coronary intervention and prognostic value of each marker.
    Okmen E; Kasikcioglu H; Sanli A; Uyarel H; Cam N
    J Invasive Cardiol; 2005 Feb; 17(2):63-7. PubMed ID: 15687525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma natriuretic peptides up to 2 years after acute myocardial infarction and relation to prognosis: an OPTIMAAL substudy.
    Squire IB; Ørn S; Ng LL; Manhenke C; Shipley L; Aarsland T; Dickstein K
    J Card Fail; 2005 Sep; 11(7):492-7. PubMed ID: 16198243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B-type natriuretic peptides: a diagnostic breakthrough for clinicians.
    McCullough PA; Omland T; Maisel AS
    Rev Cardiovasc Med; 2003; 4(2):72-80. PubMed ID: 12776016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
    Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
    Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Predictive value for long term cardiac events by admission B-type natriuretic peptide and pulmonary capillary wedge pressure in patients with chronic heart failure].
    Hu YM; Wang M; Zhao SQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Sep; 36(9):786-9. PubMed ID: 19102857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low pulse pressure is independently related to elevated natriuretic peptides and increased mortality in advanced chronic heart failure.
    Voors AA; Petrie CJ; Petrie MC; Charlesworth A; Hillege HL; Zijlstra F; McMurray JJ; van Veldhuisen DJ
    Eur Heart J; 2005 Sep; 26(17):1759-64. PubMed ID: 15833758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
    Narain VS; Gupta N; Sethi R; Puri A; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2008; 60(6):536-42. PubMed ID: 19276492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical, neurohormonal, and inflammatory markers and overall prognostic role of chronic obstructive pulmonary disease in patients with heart failure: data from the Val-HeFT heart failure trial.
    Staszewsky L; Wong M; Masson S; Barlera S; Carretta E; Maggioni AP; Anand IS; Cohn JN; Tognoni G; Latini R;
    J Card Fail; 2007 Dec; 13(10):797-804. PubMed ID: 18068611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of soluble glycoprotein 130 and cardiac natriuretic peptides as long-term predictors of heart failure progression.
    Gwechenberger M; Pacher R; Berger R; Zorn G; Moser P; Stanek B; Huelsmann M
    J Heart Lung Transplant; 2005 Dec; 24(12):2190-5. PubMed ID: 16364870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrial natriuretic peptides in heart failure: pathophysiological significance, diagnostic and prognostic value.
    Ghosh N; Haddad H
    Can J Physiol Pharmacol; 2011 Aug; 89(8):587-91. PubMed ID: 21806511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.